Page 256 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 256

Appendix Table C1.3. Trends in mortality rates (per 100,000 person-yr unless otherwise stated) or survival (continued)
                                        Author                Database       Groups             1980-84      1985-89        1990-94        1995-99      2000-04       2005-10     Statistical      Notes
                                        Year                                 (yr)                                                                                                 analysis
                                        PMID
                                              24
                                        Merrill               SEER           Local                           Referent       Referent       Referent                               OR (95% CI)      Data were
                                        2000                                 Regional                        2.36 (2.02,  2.49 (2.16,      2.36                                   for death        reported
                                        10792091                             Distant                         2.76)          2.89)          (2.05,                                 from prostate    only for
                                                                             Unknown                         5.21 (4.61,  6.95 (6.14,      2.71)                                  cancer vs.       White and
                                                                                                             5.89)          7.87)          6.35                                   non-prostate     Black
                                                                                                             2.16 (1.85,  2.13 (1.86,      (5.59,                                 cancer,          patients.
                                                                                                             2.53)          2.43)          7.21)                                  stratified by
                                                                                                             (1988-89)      (1992-93)      1.73                                   stage.
                                                                                                                                           (1.52,
                                                                                                                                           1.97)
                                                                                                                                           (1994-
                                                                                                                                           95)
                                              40
                                        Merrill               SEER           Local                           22%            22%            19%                                    NR               Excluded in
                                        2000                                 Regional                        45%            45%            41%                                                     situ cancer
                                        10647666                             Distant                         64%            67%            63%                                                     cases for
                                                                             Unknown                         41%            36%            32%                                                     this
                                                                             Percentage of                   (1988)         (1992)         (1995)                                                  analysis.
                                                                             prostate cancer
                                                                             deaths out of                                                                                                         Additional
                                                                             all deaths                                                                                                            information
                                                                             observed                                                                                                              is
                                                                             among                                                                                                                 presented
                                                                             prostate cancer                                                                                                       in Figure 4
                                                                             patients                                                                                                              of the
                                                                                                                                                                                                   paper.
                                                        86
                                        Barnholtz-Sloan       SEER-          Distant            0.32                        0.36 (0.33,                                           NR               Only
                                        2003                  Detroit        prostate cancer  (0.30,                        0.39)                                                                  patients
                                        14575366                             [5-year relative   0.34)                       (1990-1997)                                                            with distant
                                                                             survival rates]    (1980-                                                                                             prostate
                                                                                                1989)                                                                                              cancer



















                                                                                                                        C-46
   251   252   253   254   255   256   257   258   259   260   261